Dark
Light
Today: November 27, 2024
March 11, 2024
1 min read

Collaborative Innovation: OurCrowd AI Fund X NVIDIA Inception

TLDR:

  • OurCrowd AI Fund is collaborating with NVIDIA Inception to fast track AI startups into the program.
  • The fund provides access to investment opportunities in AI companies and generative AI space.

OurCrowd AI Fund has announced a collaboration with NVIDIA Inception to provide select artificial intelligence startups with a fast track into the NVIDIA Inception program. The fund aims to offer investors access to revolutionary global venture capital opportunities in AI companies and generative AI space. With an investment focus on mission-centric AI companies, the fund will invest in 20-25 venture investments diversified by stage and geography. Several companies have already been approved to be part of the AI Fund, including D-ID, One Zero Digital Bank, and Polaris Quantum Biotech.

The collaboration with NVIDIA Inception will allow qualifying companies in the fund to access a program tailored to nurture startups and equip them for success. NVIDIA Inception provides startups with cutting-edge technology, connections with venture capitalists, and access to technical resources and tools. Qualifying startups selected for the OurCrowd AI Fund portfolio will be fast-tracked into Inception, gaining access to NVIDIA training courses, collaboration opportunities, and cloud credits. OurCrowd is recognized as Israel’s most active AI investor, with investments across 81 AI companies worldwide and several successful exits.

The collaboration between OurCrowd AI Fund and NVIDIA Inception aims to develop the next generation of AI startups and shape the impact of AI on various aspects of life. By providing startups with the necessary support and resources, the program seeks to advance the growth and success of AI companies in the industry.

Previous Story

Enhancing UAE-South Korea Economic Ties with Investopia 2024

Next Story

RasMal’s Expansion: Acquiring Pentugram for Private Capital Management

Latest from Blog

Go toTop